Boston Trust Walden Corp Bristol Myers Squibb CO Transaction History
Boston Trust Walden Corp
- $14.1 Billion
- Q3 2024
A detailed history of Boston Trust Walden Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boston Trust Walden Corp holds 14,207 shares of BMY stock, worth $819,459. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,207
Previous 14,211
0.03%
Holding current value
$819,459
Previous $590,000
24.58%
% of portfolio
0.01%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.15 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.52 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...